The Usefulness of Cell Surface Markers in Predicting the Prognosis of Non-Hodgkin's Lymphomas

References

• Rosenberg S. A., Berard C. W., Brown BW, Jr, et al. National Cancer Institute Sponsored Study of Classifications of Non-Hodgkin's Lymphoma: Summary and Description of a Working Formulation for Clinical Usage. Cancer 1982; 49: 2112–35
   PubMed Web of Science ®Google Scholar
• Nathwani B. N. Classifying non-Hodgkin's Lymphomas. Malignant lymphoma, C. W. Berard, R. F. Dorfman, N. Kaufman. Williams and Wilkins, Baltimore 1987; 18–80
   Google Scholar
• Simon R., Durrleman S., Hoppe R. T., et al. Long-term follow-up of 1153 patients with non-Hodgkin's lymphomas. Ann Int Med 1988; 109: 939–45
   PubMed Web of Science ®Google Scholar
• Lukes R. J., Collins R. D. New Approaches to the Classification of the lymphomata. Br J Cancer 1975; 31(Suppl II)1–28
   Google Scholar
• Spangrude G. J., Heimfeld S, Weissman I. L. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58–62
   PubMed Web of Science ®Google Scholar
• Jordan C. T., McKeam JP, Lemischka I. R. Cellular and developmental properties of fetal hematopoietic stem cells. Cell 1990; 61: 953–63
   PubMed Web of Science ®Google Scholar
• Ploemacher R. C., Brons R. H. Separation of CFU-S from primitive stem cells responsible for reconstitution of the bone marrow hematopoietic stem cell compartment following irradiation: evidence for a pre CFU-S cell. Exp Hematol 1989; 17: 263–6
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Tantravaki R., Canellos G. P., et al. T- Cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. Blood 1983; 61: 640–4
   PubMed Web of Science ®Google Scholar
• Sawyers C. L., Denny CT, Witte O. N. Leukemia and the disruption of normal hematopoiesis. Cell 1991; 64: 337–50
   PubMed Web of Science ®Google Scholar
• Knapp W., Doerken B., Riebar P., et al. CD antigens 1989. Am J Pathol 1989; 135: 420–1
   Google Scholar
• Knapp W., Doerken B., Rieber P., et al. Leukocyte typing IV. Oxford University Press, New York 1989
   Google Scholar
• Lydyard P., Grossi C. The lymphoid system. Immunology, I. Roitt, J. Brostoff, D. Male. Grover Medical Publishing, New York 1989; 3.1–3.10
   Google Scholar
• Gutman G. A., Weissman I. L. Lymphoid tissue architecture. Experimental analyses of the origin and distribution of T cells and B cells. Immunology 1972; 23: 465–79
   PubMed Web of Science ®Google Scholar
• Eltringham J. R., Weissman I. L. Differential effects of local lymphoid irradiation on delayed hypersensitivity and the serum antibody response in rats: antigen injection before X-rays. J Immunol 1971; 106: 1185–90
   Google Scholar
• Paran M., Sachs L., Borak Y., et al. In vitroinduction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci USA 1970; 67: 1542–9
   PubMed Web of Science ®Google Scholar
• Moore M. A., Williams N., Metcalf N., et al. Control of human leukemic cell proliferation and differentiation in agar cultures. Cell differentiation, R. Harris, P. Allen, D. Viza. Munksgaard, Copenhagen 1972; 144–50
   Google Scholar
• Greaves M. F. Differentiation-linked leukemogenesis in lymphocytes. Science 1986; 234: 697–704
   PubMed Web of Science ®Google Scholar
• Norton A. J., Isaacson P. G. Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded tissues: I and II. Histopathology 1989; 14: 437–46
   PubMed Web of Science ®Google Scholar
• Stansfield A. G., Diebold J., Kapanci Y., et al. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292–3
   Web of Science ®Google Scholar
• Johnston RB, Jr. Monocytes and macrophages. N Engl J Med 1988; 318: 747–52
   PubMed Web of Science ®Google Scholar
• Groopman J. E., Golde D. W. The histiocytic disorders: a patho-physiologic analysis. Ann Intern Med 1981; 94: 95–107
   Google Scholar
• Drexler H. G., Leber B. F. The nature of the Hodgkin cell. Blut 1988; 56: 135–7
   PubMedGoogle Scholar
• Chan W. C., Winton EF, Waldmann T. A. Lymphocytosis of large granular lymphocytes. Arch Intern Med 1986; 146: 1201–3
   PubMed Web of Science ®Google Scholar
• Loughran T. P., Kadin M. E., Starkebaum G., et al. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med 1985; 102: 169–75
   PubMed Web of Science ®Google Scholar
• Royston I., Majda J., Baird S. M., et al. Human T cell antigens defined by monoclonal antibodies. The 65,000-dalton antigen of T cells (T-65), is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J Immunol 1980; 125: 725–31
   PubMed Web of Science ®Google Scholar
• Gadol N., Ault K. A. Phenotypic and functional characterization of human leu 1 (CD25) B cells. Immunol Rev 1986; 93: 23–5
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Gobbi M., Bofill M., et al. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 1982; 155: 623–8
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Nadler L. M. Immunologic markers in non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 1991; 5: 871–89
   PubMed Web of Science ®Google Scholar
• Harris N. L., Nadler LM, Bhan A. K. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities. Am J Pathol 1984; 117: 262–72
   PubMed Web of Science ®Google Scholar
• David J. R. Organs and cells of the immune system. Scientific American medicine, E. Rubinstein, D. Federman. Scientific American, New York 1990; 1–14
   Google Scholar
• Miller JFAP, Mitchell G. Thymus and antigen reactive cells. Transplant Rev 1969; 1: 3–42
   PubMedGoogle Scholar
• Schlesinger M. Antigens of the thymus. Prog Allergy 1972; 16: 214–99
   PubMedGoogle Scholar
• Lay W. H., Mendes N. F., Bianco C., et al. Binding of sheep red blood cells to a large population of human lymphocytes. Nature 1971; 230: 531–2
   PubMed Web of Science ®Google Scholar
• Wybran J., Carr MC, Fudenberg H. H. The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest. 1972; 51: 2537–43
   PubMed Web of Science ®Google Scholar
• Sell S., Gell PGH. Studies on rabbit lymphocytes. in vitro. I. Stimulation of blast transformation with antiallotype serum. J Exp Med. 1965; 122: 423–39
   Google Scholar
• Lukes R. J., Collins R. D. Immunological characterization of human malignant lymphomas. Cancer 1974; 122: 1488–1503
   Google Scholar
• Rappaport H., Winter WJ, Hicks E. B. Follicular lymphoma: a reevaluation of its position in the scheme of malignant lymphoma based on a survey of 253 cases. Cancer 1956; 9: 792–821
   PubMed Web of Science ®Google Scholar
• Rappaport H. Tumors of the hematopoietic system. Atlas of tumor pathology. Armed Forces Institute of Pathology, Washington, DC 1966, Sect 3, Fasicle 8.
   Google Scholar
• Nathwani B. N., Kim H, Rappaport H. Malignant lymphoma, lymphoblastic. Cancer 1976; 33: 964–83
   Google Scholar
• Cossman J., Chused T. N., Fisher R. I., et al. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 1983; 43: 4486–90
   PubMed Web of Science ®Google Scholar
• Cossman J., Jaffe ES, Fisher R. I. Immunology phenotypes of diffuse, aggressive non-Hodgkin's lymphomas. Cancer 1984; 54: 1310–17
   PubMed Web of Science ®Google Scholar
• Knowles D. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. Am J Pathol 1989; 134: 761–86
   PubMed Web of Science ®Google Scholar
• Lippman S. N., Miller T. P., Spier C. M., et al. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood. 1988; 72: 436–41
   PubMed Web of Science ®Google Scholar
• Armitage J. O., Vose J. M., Linder J., et al. Clinical significance of immunophenotype in diffuse, agressive, non-Hodgkin's lymphoma. J Clin Oncol. 1989; 7: 1783–90
   PubMed Web of Science ®Google Scholar
• Kwak L. W., Wilson M., Weiss L. M., et al. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience. J Clin Oncol 1991; 9: 1426–31
   PubMed Web of Science ®Google Scholar
• Coiffier B., Brousse N., Peuchmaur M., et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann Oncol. 1990; 1: 45–50
   PubMed Web of Science ®Google Scholar
• Foon K. A., Rai KR, Gale R. P. Chronic lymphocyte leukemia: new insights into biology and therapy. Ann Int Med 1990; 113: 525–39
   PubMed Web of Science ®Google Scholar
• Pangalis G. A., Nathwani BN, Rappaport H. Malignant lymphoma, well-differentiated lymphocytic: its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenstrom. Cancer 1977; 39: 999–1040
   PubMed Web of Science ®Google Scholar
• James S. P., Murakawa Y., Kanof M. E., et al. Multiple roles of Leu 8/MEL 14 in leukocyte adhesion function. Immunol Res 1991; 10: 282–92
   Google Scholar
• Gallatin W. M., Weissman IL, Butcher E. C. A cell surface molecule involved in organ-specific homing of lymphocytes. Nature 1983; 304: 30–4
   PubMed Web of Science ®Google Scholar
• Jalkanen S., Joensuu H., Soderstrom K., et al. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invest 1991; 87: 1835–40
   PubMed Web of Science ®Google Scholar
• Inghirami G., Wieczorek R., Zhu B. Y., et al. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood 1988; 72: 1431–4
   PubMed Web of Science ®Google Scholar
• Stauder R., Greil R., Shultz T. F., et al. Expression of leucocyte function associated antigen-1 and 7F7- antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin's lymphomas and leukaemias: possible influence on growth pattern and leukaemic behavior. Clin Exp Immunol 1989; 77: 234–8
   PubMed Web of Science ®Google Scholar
• Itami M., Takenouchi T., Tamaru J., et al. Expression of functional molecules in non-Hodgkin's lymphoma. Correlation with bone marrow involvement and serum LDH value. Acta Pathol 1991; 41: 277–89
   Google Scholar
• Lennert K., Mohri N., Stein H., et al. Histopathology and diagnosis of non-Hodgkin's lymphomas. Malignant lymphomas other than Hodgkin's Disease. Springer- Verlag, New York 1978; 111–69
   Google Scholar
• Dillman R. O., Mick R, McLntyre O. R. Pentostatin in chronic lymphocytic leukemia: a phase II trial of cancer and leukemia group B. J Clin Oncol 1989; 7: 433–8
   PubMed Web of Science ®Google Scholar
• Keating M. J., Kantarjian H., Talpaz M., et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19–25
   PubMed Web of Science ®Google Scholar
• Levy R., Wamke R., Dorfman R., et al. The monoclonality of human B-cell lymphomas. J Exp Med 1977; 145: 1014–28
   PubMed Web of Science ®Google Scholar
• Warnke R. A., Weiss L. M. B-Cell malignant lymphomas: an immunologic perspective. Malignant lymphoma, C. W. Berard, R. F. Dorfman, N. Kaufman. Williams and Wilkins, Baltimore 1987; 88–103
   Google Scholar
• Turner R. R., Egbert P., Warnke R. A. Lymphocytic infiltrates of the conjuctiva and orbit: immunohistochemical staining of 16 cases. Am J Clin Pathol 1984; 81: 447–52
   Google Scholar
• Weiss L. M., Yousem SA, Warnke R. A. Non-Hodgkin's lymphomas of the lung: a study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis. Am J Pathol 1985; 9: 480–90
   Google Scholar
• Stein H., Gerders J, Mason D. Y. The normal and malignant germinal centre. Clin Hematol 1982; 11: 531–560
   PubMedGoogle Scholar
• Paulson S., Sheehan R. G., Stone M. J., et al. Large cell lymphomas of the stomach: improved prognosis with complete resection of all intrinsic gastrointestinal disease. J Clin Oncol. 1983; 1: 263–9
   PubMed Web of Science ®Google Scholar
• Morgan K., MacLenoran K. A., Narula A., et al. Non-Hodgkin's lymphoma of the larynx (stage IE). Cancer 1989; 64: 1123–7
   Google Scholar
• Lukes R. J., Collins R. D. Immunologic characterization of human malignant lymphomas. Cancer 1974; 34: 1488–503
   PubMed Web of Science ®Google Scholar
• Lukes R. J., Parker J. W., Taylor C. R., et al. Immunologic approach to non-Hodgkin's lymphoma and related leukemias. An analysis of the results of multiparameter studies of 425 cases. Sem Hematol 1978; 15: 322–51
   PubMed Web of Science ®Google Scholar
• Gerdes J., Schwab U., Lemke H., et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13–20
   PubMed Web of Science ®Google Scholar
• Gerdes J., Lemke H., Baisch H., et al. Cell cycle analysis of a cell proliferation-associated human antigen defined by the monoclonal antibody Ki- 67. J Immunol 1984; 133: 1710–5
   PubMed Web of Science ®Google Scholar
• Lang W., Kienzle S, Diehl V. Proliferation kinetics of malignant non-Hodgkin's lymphomas related to histopathology of lymph node biopsies. Virchow's Arch (V) 1980; 389: 397–407
   PubMed Web of Science ®Google Scholar
• Donhuijsen K. Mitoses in non-Hodgkin's lymphomas: frequency and prognostic relevance. Path Res Pract 1987; 182: 352–7
   PubMed Web of Science ®Google Scholar
• Costa A., Bonadonna G., Villa E., et al. Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst 1981; 66: 1–5
   PubMed Web of Science ®Google Scholar
• Laurence J., Coleman M., Allen S. L., et al. Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six drug COP-BLAM regimen. Ann Intern Med 1982; 97: 190–5
   PubMed Web of Science ®Google Scholar
• Skarin A. T., Cannellos G. P., Rosenthal D. S., et al. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol. 1983; 1: 91–8
   PubMed Web of Science ®Google Scholar
• Fisher R. I., De Vita V. T., Hubbard S. M., et al. Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of pro MACE and MOPP chemotherapy. Ann Intern Med 1989; 98: 304–9
   Google Scholar
• Klimo P., Connors J. M. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 1985; 102: 596–602
   PubMed Web of Science ®Google Scholar
• Picker L. J., Weiss L. M., Meduros L. J., et al. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987; 128: 181–201
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Bousvaros A., Bymes R. K., et al. Monoclonal antibody phenotyping of B cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience. Am J Pathol 1985; 121: 514–21
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Boyd A. W., Anderson K. C., et al. Immunologic heterogeneity of diffuse large cell lymphoma. Blood 1985; 65: 630–7
   PubMed Web of Science ®Google Scholar
• Stein H., Mason D. Y. Immunological analysis of tissue sections in diagnosis of lymphoma. Recent advances in hematology, A. V. Hoffbrand. Churchill-Livingstone, Edinburgh 1985; 127–69
   Google Scholar
• Gaynor E. R., Ultmann J. E. Overview on current strategy of the treatment of non-Hodgkin's lymphomas. Dev Oncol 1985; 32: 441–54
   Google Scholar
• Weisenburger D. D., Harrington DS, Armitage J. O. (1987) B-Cell neoplasia recapitulates the normal humoral immune response (abstract). Third International Conference Malignant Lymphoma. 1987. Lugano, Switzerland, 22
   Google Scholar
• Foon K. A., Todd R. F. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Weiner G. J., Kaminski M. S. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B-cell lymphoma. J Immunol 1990; 144: 2436–49
   PubMed Web of Science ®Google Scholar
• Miller R. A., Maloney D. G., Wamke R., et al. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med 1982; 306: 517–22
   PubMed Web of Science ®Google Scholar
• Rankin E. M., Hickman A., Somers R. N., et al. Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies. Blood 1985; 65: 1373–81
   PubMed Web of Science ®Google Scholar
• Sugelman M. H., Cleary M. L., Wamke R., et al. Frequent biclonality and Ig gene alteration among B-cell lymphomas that show multiple histologic forms. J Exp Med 1985; 161: 850–63
   Google Scholar
• Sklar J., Cleary M., Theilemen S. K., et al. Biclonal B-cell lymphoma. N Engl J Med 1984; 311: 20–7
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Meeker T. C., Ley S., et al. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from human B cell lymphoma. Cell 1986; 44: 97–106
   PubMed Web of Science ®Google Scholar
• Seibani K., Nathwani B. N., Winberg C. D., et al. Small lymphocytic lymphoma. Morphologic and immunologic progression. Am J Clin Pathol 1985; 84: 237–43
   Google Scholar
• Van Dongen J. J., Hooijkass H., Michiels J. J., et al. Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements. Blood 1984; 64: 571–75
   PubMed Web of Science ®Google Scholar
• Mosier D., Gulizia R., Baird S. M., et al. Studies of HIV infection and the development of Epstein-Barr virus-related B-cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Microbiol Immunol 1989; 152: 195–9
   PubMed Web of Science ®Google Scholar
• Rowe M., Young L. S., Crocker H., et al. Epstein-Barr virus (EBV)-associated lymphoproli-ferative disease in the SCID mouse model: implications for the pathogenesis of EB V positive lymphomas in man. J Exp Med 1991; 173: 147–58
   PubMed Web of Science ®Google Scholar
• Hanto D. W., Birkenbach G., Frizzera G., et al. Confirmation of the heterogeneity of post-transplant Epstein-Barr-virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. Transplantation 1989; 47: 458–64
   PubMed Web of Science ®Google Scholar
• Zutter M. M., Martin P. J., Sale G. E., et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520–9
   PubMed Web of Science ®Google Scholar
• Kipps T. J., Robbins B. A., Tefferi W., et al. CD5-positive B cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies. Am J Pathol 1990; 136: 809–16
   PubMed Web of Science ®Google Scholar
• Solomon A., Weiss D. T., Macy S. D., et al. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies. Am J Pathol 1990; 137: 855–62
   PubMedGoogle Scholar
• Schmid C., Sargent C, Isaacson P. G. L and H cells of nodular lymphocyte predominant Hodgkin's disease show immunoglobulin light chain restriction. Am J Pathol 1991; 139: 1281–90
   PubMed Web of Science ®Google Scholar
• Gerdes J., Carsten-Schleuter L. L., Duchrow M., et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki 67. Am J Pathol 1991; 138: 867–73
   PubMed Web of Science ®Google Scholar
• Kamel O. W., LeBrun D. P., Davis R. E., et al. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti pcna/cyclin 19A2: correlation with Ki-67 labeling. Am J Pathol 1991; 138: 1471–7
   PubMed Web of Science ®Google Scholar
• Schwartz B. R., Pinkus G., Bacus S., et al. Cell proliferation in non-Hodgkin's lymphomas: digital image analysis of Ki 67 antibody staining. Am J Pathol 1989; 134: 327–36
   PubMed Web of Science ®Google Scholar
• Metter G. E., Nathwani B. N., Burke J. S., et al. Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the repository center and pathology panel for lymphoma clinical studies. J Clin Oncol. 1985; 3: 24–38
   Google Scholar
• Grogan T. M., Lippman S. M., Spier C. M., et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by monoclonal antibody Ki 67. Blood 1988; 71: 1157–60
   PubMed Web of Science ®Google Scholar
• Medeiros L. I., Picker L. J., Gelb A. B., et al. Numbers of host “helper” T cells and proliferating cells predict survival in diffuse small-cell lymphomas. J Clin Oncol 1989; 7: 1009–17
   PubMed Web of Science ®Google Scholar
• Hall P. A., Richards M. A., Gregory W. M., et al. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988; 154: 223–35
   PubMed Web of Science ®Google Scholar
• Holte H., Davies C. D., Kvaly S., et al. The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomas. Int J Cancer 1987; 39: 590–4
   PubMed Web of Science ®Google Scholar
• Holte H., Davies C. D., Baiske K., et al. Ki 67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumor progression in low-grade B-cell lymphoma. Int J Cancer 1989; 44: 975–80
   PubMed Web of Science ®Google Scholar
• Salter D. M., Krajewski A. S., Sheelan T., et al. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma. J Pathol 1989; 159: 211–20
   PubMed Web of Science ®Google Scholar
• Spier CM, Grogan T. M., Lippman S. M., et al. The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma. Am J Pathol 1988; 133: 118–26
   PubMed Web of Science ®Google Scholar
• Schuurman H. J., Huppes W, Verdonck L. Immunophenotyping of non-Hodgkin's lymphomas: correlation with relapse-free survival. Am J Pathol 1988; 131: 102–11
   PubMed Web of Science ®Google Scholar
• Horning S. J., Doggett R. S., Warnke R. A., et al. Clinical relevance of immunologic phenotype in diffuse, large cell lymphoma. Blood 1984; 5: 1209–15
   Google Scholar
• Hieter P. A., Korsmeyer S. J., Waldmann T. A., et al. Immunoglobulin K light-chain genes are deleted or rearranged in X producing B cells. Nature 1981; 290: 368–72
   PubMed Web of Science ®Google Scholar
• Frisman D., Slovin S., Baird S. M., et al. Characterization of a monoclonal antibody that reacts with an activation antigen on human B cells: reactions on mitogen-stimulated blood lymphocytes and cells of normal lymph nodes. Blood 1983; 62: 1224–9
   Google Scholar
• Yukawa K., Kikutani H., Owaki H., et al. A B-cell specific differentiation antigen CD23, is a receptor for IgE (FcER) on lymphocytes. J Immunol 1987; 138: 2576–80
   PubMed Web of Science ®Google Scholar
• Gordon J., Guy G. R. The molecules controlling B lymphocytes. Immunol Today. 1987; 8: 339–44
   PubMedGoogle Scholar
• Gordon J., Webbs AJ, Walker L. Evidence for an association between CD23 and the receptor for a low molecular weight B-cell growth factor. Eur J Immunol 1986; 16: 1627–30
   PubMed Web of Science ®Google Scholar
• Laurent G., Al Saati T., Olive D., et al. Expression of Tac antigen in B cell lymphomas. Clin Exp Immunol 1986; 65: 353–62
   Google Scholar
• Harris N. L., Bhan A. K. Mantle-zone lymphoma, a pattern produced by lymphomas of more than one cell type. Am J Surg Pathol 1985; 9: 872–82
   Google Scholar
• Weisenburger D. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin. Leukemia 1991; 5(Suppl 1)26–9
   PubMedGoogle Scholar
• Weisenburger D. D., Linder J., Daley D. T., et al. Intermediate lymphocytic lymphomas. Hum Pathol 1987; 18: 781–90
   PubMed Web of Science ®Google Scholar
• Watanabe S., Sato Y., et al. Shimoyama Immunoblastic lymphadenopathy, angioimmuno-blastic lymphadenopathy, and IBL-like T-cell lymphoma, a spectrum of T-cell neoplasia. Cancer 1986; 58: 2224–32
   PubMed Web of Science ®Google Scholar
• Grogan T., Spier C., Wert D. P., et al. Immunologic complexity of lymphoblastic lymphoma. Diag Immunol 1986; 4: 81–8
   PubMedGoogle Scholar
• Grogan T. M., Fielder K., Rangel C., et al. Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes. Am J Pathol 1985; 83: 279–88
   Google Scholar
• Pui C. H., Ip S. H., Dodge R. K., et al. Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients. Blood 1988; 72: 1015–21
   PubMed Web of Science ®Google Scholar
• Beljaards R. C., Meier C. J., Scheffer E., et al. Prognostic significance of CD30 (Ki 67/Ber H2) expression in primary cutaneous large-cell lymphomas of T-cell origin, a clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 1989; 135: 1169–78
   PubMed Web of Science ®Google Scholar
• Piris M., Brown D. C., Gatter K. C., et al. CD30 expression in non-Hodgkin's lymphomas. Histopathology 1990; 17: 211–8
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Cancer cytogenetics. Alan R Liss, New York 1987; 201–25
   Google Scholar
• Manlov G., Manalova Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature 1982; 237: 33–4
   Google Scholar
• Zech L., Haugland U., Nilsson K., et al. Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 1976; 17: 47–56
   PubMed Web of Science ®Google Scholar
• Fukuhara S., Rowley J. D., Variakojis D., et al. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res 1979; 39: 3119–28
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Okin M. M., Theologides A., et al. Recurrent chromosomal defects are found in most patients with non-Hodgkin's lymphoma. Cancer Genet Cytogenet 1984; 13: 17–28
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Okin M. M., Kaplan M. E., et al. Distinctive chromosomal abnormalities in histological subtypes of non-Hodgkin's lymphoma. N Eng J Med 1982; 307: 1231–6
   PubMed Web of Science ®Google Scholar
• Dalla-Favera T., Bergni M., Erikson J., et al. Human. c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 1982; 79: 7824–7
   PubMed Web of Science ®Google Scholar
• Taub R., Kirsch I., Morton C., et al. Translocation of. c-myc gene into the immunoglobulin heavy chain locus in human Burkitt's lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 1982; 79: 7837–41
   PubMed Web of Science ®Google Scholar
• Bemheim A., Berger R, Lenoir G. Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8), and t(8;22) translocations. Cancer Genet Cytogenet. 1981; 3: 307–15
   Google Scholar
• Lenoir G. M., Preud'homme JL, Bemheim A., et al. Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature 1982; 298: 474–6
   PubMed Web of Science ®Google Scholar
• Chaganti RSK. Cytogenetics of leukemia and lymphoma. Malignant lymphoma, C. S. Berard, R. F. Dorfman, N. Kaufman. Williams and Wilkins, Baltimore 1987; 184–203
   Google Scholar
• Kristoffersson U., Heim S., Mandahl N., et al. Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin lymphoma. Cancer Genet Cytogenet 1987; 25: 55–64
   PubMed Web of Science ®Google Scholar
• Bloomfield C. D., Arthur D. C., Levine E. G., et al. Chromosome abnormalities in maligant lymphoma: biologic and clinical correlations. Modern trends in human leukemia VI, R. Neth, R. C. Gallo, M. F. Greaves. Springer-Verlag, Berlin/Heidelberg 1985; 27: 145–149
   Google Scholar
• Tsujimoto Y., Finger L. R., Yunis J. J., et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;8) chromosome translocation. Science 1987; 226: 1097–9
   Google Scholar
• Yunis J. J., Frizzera G., Oken M. M., et al. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med 1987; 316: 79–84
   PubMed Web of Science ®Google Scholar
• Rowley J. D. Ph' positive leukemia, including chronic myelogenous leukemia. Clin Hematol 1980; 9: 55–86
   PubMedGoogle Scholar
• Warzynski M. J., Otto R. N., Steingart R. H., et al. MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis. Leuk Res 1991; 15: 357–65
   Google Scholar
• Hall P. A., d'Ardenne AJ, Stansfield A. G. Paraffin section immunohistochemistry. I. Non-Hodgkin's lymphoma. Histopathology 1988; 13: 149–60
   PubMed Web of Science ®Google Scholar